Arbor Biotechnologies
Cambridge, MA
Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
arbor.bioCompany Details
Founded
- 2016
Employees
- Between 50 - 200 employees
Raised
- $304,500,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Devyn Smith
Founders
- David WaltDavid ScottFeng ZhangWinston Yan
Company Collections
These are collections Arbor Biotechnologies is a part of. Click on the collection name to view similar companies.
Arbor Biotechnologies' Industries
Arbor Biotechnologies Headquarters Location
Total Amount Raised: $304,500,000
Arbor Biotechnologies Funding Rounds
Series C
$73,900,000
Series C Investors
Arch Venture PartnersTCGXRevelation PartnersPartners InvestmentQatar Investment AuthorityAlly Bridge GroupArrowMark Colorado HoldingsDeep Track CapitalTemasekT. Rowe PriceSurveyor CapitalVertex PharmaceuticalsPiper Heartland Healthcare CapitalAberdeenKerna VenturesSeries B
$215,000,000
Series B Investors
Ally Bridge GroupTCGXTemasekS32Woodline PartnersRidgeback Capital ManagementGreatPoint VenturesT. Rowe PriceHenderson Global InvestorsIllumina VenturesOno Venture InvestmentVertex PharmaceuticalsDeep Track CapitalSurveyor CapitalTekla Capital ManagementArch Venture PartnersTao Capital PartnersLogos CapitalArrowMark Colorado HoldingsSeries A
$15,600,000
Series A Investors
Arch Venture PartnersAlexandria Real Estate Equities
Arbor Biotechnologies Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Arbor Biotechnologies.